NOVN - ノバン (Novan Inc.)

NOVNのニュース

   Novan, Inc. (NOVN) CEO Paula Stafford on Q2 2022 Results - Earnings Call Transcript  2022/08/12 02:29:11 Seeking Alpha
Novan, Inc. (NASDAQ:NASDAQ:NOVN) Q2 2022 Earnings Conference Call August 11, 2022, 08:30 ET Company Participants Paula Stafford - President, CEO & Chairwoman John Gay - CFO &…
   Recap: Novan Q2 Earnings  2022/08/11 13:07:56 Benzinga
Novan (NASDAQ: NOVN ) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here''s what investors need to know about the announcement. Earnings Novan beat estimated earnings by 22.81%, reporting an EPS of $-0.44 versus an … Full story available on Benzinga.com
   Novan GAAP EPS of -$0.44 beats by $0.15, revenue of $6.16M misses by $0.44M  2022/08/11 10:37:06 Seeking Alpha
Novan press release (NOVN): Q2 GAAP EPS of -$0.44 beats by $0.15.Revenue of $6.16M (+721.3% Y/Y) misses by $0.44M.As of June 30, 2022, Novan had a total cash and cash…
   Novan Reports Second Quarter 2022 Financial Results and Provides Corporate Update  2022/08/11 10:30:00 GlobeNewswire
– Total revenue of $6.2 million for the second quarter 2022 –
   Earnings Scheduled For August 11, 2022  2022/08/11 09:09:16 Benzinga
Companies Reporting Before The Bell • Magic Software (NASDAQ: MGIC ) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million. • Dingdong (Cayman) (NYSE: DDL ) is likely to report earnings for its second quarter. • Evelo Biosciences (NASDAQ: EVLO ) is projected to report earnings for its second quarter. • Affimed (NASDAQ: AFMD ) is estimated to report quarterly loss at $0.17 per share on revenue of $8.67 million. • CorEnergy Infr Trust (NYSE: CORR ) is expected to report earnings for its second quarter. • Six Flags Entertainment (NYSE: SIX ) is expected to report earnings for its second quarter. • Where Food Comes From (NASDAQ: WFCF ) is projected to report earnings for its second quarter. • BurgerFi International (NASDAQ: BFI ) is estimated to report earnings for its second quarter. • Smith-Midland (NASDAQ: SMID ) is expected to report earnings for its second quarter. • Kala Pharmaceuticals (NASDAQ: KALA ) is expected to report earnings for its second quarter.
   JTC Team to Host Virtual Investor Innovation in Dermatology Spotlight Event Featuring Novan, Inc.  2022/04/25 14:00:00 Wallstreet:Online
- Live video webcast event with members of Novan, Inc. management on Tuesday, April 26th at 2:00 PM ET -FRENCHTOWN, NJ / ACCESSWIRE / April 25, 2022 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today …
   Novan Inc. (NASDAQ: NOVN) Shares Have Been Down About -29.74% Year-To-Date Since The Beginning Of 2022  2022/04/23 17:00:00 Marketing Sentinel
During the last session, Novan Inc. (NASDAQ:NOVN)’s traded shares were 0.41 million, with the beta value of the company hitting 0.03. At the end of the trading day, the stock’s price was $2.93, reflecting an intraday loss of -1.68% or -$0.05. The 52-week high for the NOVN share is $20.74, that puts it down -607.85 … Novan Inc. (NASDAQ: NOVN) Shares Have Been Down About -29.74% Year-To-Date Since The Beginning Of 2022 Read More »
   Novan to Participate in the Virtual Investor Innovation in Dermatology Spotlight Event  2022/04/20 13:05:00 GlobeNewswire
Live moderated video webcast with members of the Novan management team on Tuesday, April 26th at 2:00 PM ET Live moderated video webcast with members of the Novan management team on Tuesday, April 26th at 2:00 PM ET
   Novan (NOVN) Investor Presentation - Slideshow  2022/03/25 18:10:08 Seeking Alpha
   2022 Women in Business Awards: Tomoko Maeda Chubachi – Novan  2022/03/25 03:00:00 Business Journals
Meet the winners in our 2022 Women in Business Awards!
   Novan (NOVN) Investor Presentation - Slideshow  2022/03/25 18:10:08 Seeking Alpha
   2022 Women in Business Awards: Tomoko Maeda Chubachi – Novan  2022/03/25 03:00:00 Business Journals
Meet the winners in our 2022 Women in Business Awards!
   Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology''s (AAD) 2022 Annual Meeting  2022/03/24 13:00:00 Benzinga
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. ("the Company" or "Novan") (NASDAQ: NOVN ), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for the treatment of molluscum contagiosum was selected for an oral presentation at a late-breaker session at the American Academy of Dermatology''s (AAD) 2022 Annual Meeting. Details of the abstract presentation are as follows: Title: Berdazimer 10.3% Gel (SB206): A Novel, Topical Nitric Oxide Releasing Medication: Results from a Pivotal Phase 3 Study in Patients (Children and Adults) with Molluscum Contagiosum Session: Clinical Studies/Pediatric Date & Time: March 26, 2022, at 10:20am ET Location: Rm. 253A The presentation will be given by Dr. John Browning M.D., F.A.A.D, F.A.A.P., MBA, Adjunct Associate Professor of Pediatrics and Dermatology at UT Health San Antonio and Baylor College of Medicine, and a Principal Investigator in the B-SIMPLE4 study. "We are pleased to present the compelling data from our Phase 3 study, BSIMPLE-4, at this prestigious dermatology event.
   Novan Acquires EPI Health To Bolster Commercial Force For Potential Marketing Of Its lead Products  2022/03/11 16:10:27 Benzinga
Novan Inc (NASDAQ: NOVN ) has acquired EPI Health LLC , a specialty pharmaceutical company focused on the U.S. dermatology market. EPI Health offers a product portfolio that includes four prescription products across psoriasis, rosacea, dermatosis, and acne, with a 2021 operating revenue of $17.6 million. Deal consideration of $27.5 million consists of $11.0 million in cash and $16.5 million in … Full story available on Benzinga.com
   Novan acquires EPI Health for upfront payment of $27.5M and milestone payment of $23.5M  2022/03/11 11:42:39 Seeking Alpha
Novan (NOVN) is acquiring EPI Health, LLC, a specialty pharmaceutical company focused on the U.S

calendar